News Releases

Month Year

Month Year

Jan 26, 2004

Insmed Obtains Patent Rights for Extreme Insulin Resistance From Fujisawa
Dec 15, 2003

Insmed Receives FDA Orphan Drug Designation For rhIGF-I/rhIGFBP-3, SomatoKine, for Extreme Insulin Resistance
Dec 3, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San Antonio Breast Cancer Symposium
Dec 2, 2003

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
Nov 17, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation